Literature DB >> 17324361

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy.

Roger J Packer1.   

Abstract

Entities:  

Year:  2007        PMID： 17324361

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  7 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

3.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

4.  Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

Authors:  R J Packer; J Goldwein; H S Nicholson; L G Vezina; J C Allen; M D Ris; K Muraszko; L B Rorke; W M Wara; B H Cohen; J M Boyett
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

5.  Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

Authors:  P R Thomas; M Deutsch; J L Kepner; J M Boyett; J Krischer; P Aronin; L Albright; J C Allen; R J Packer; R Linggood; R Mulhern; J A Stehbens; J Langston; P Stanley; P Duffner; L Rorke; J Cherlow; H S Friedman; J L Finlay; T J Vietti; L E Kun
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

6.  Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

Authors:  V Oyharcabal-Bourden; C Kalifa; J C Gentet; D Frappaz; C Edan; P Chastagner; E Sariban; A Pagnier; A Babin; F Pichon; S Neuenschwander; M Vinchon; D Bours; V Mosseri; C Le Gales; M Ruchoux; C Carrie; F Doz
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544

7.  Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

Authors:  Roger E Taylor; Clifford C Bailey; Kath Robinson; Claire L Weston; David Ellison; James Ironside; Helen Lucraft; Richard Gilbertson; Diana M Tait; David A Walker; Barry L Pizer; John Imeson; Linda S Lashford
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.